Cargando…
A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma
Clear cell renal cell carcinomas (ccRCCs) display divergent clinical behaviours. Molecular markers might improve risk stratification of ccRCC. Here we use, based on genome-wide CpG methylation profiling, a LASSO model to develop a five-CpG-based assay for ccRCC prognosis that can be used with formal...
Autores principales: | Wei, Jin-Huan, Haddad, Ahmed, Wu, Kai-Jie, Zhao, Hong-Wei, Kapur, Payal, Zhang, Zhi-Ling, Zhao, Liang-Yun, Chen, Zhen-Hua, Zhou, Yun-Yun, Zhou, Jian-Cheng, Wang, Bin, Yu, Yan-Hong, Cai, Mu-Yan, Xie, Dan, Liao, Bing, Li, Cai-Xia, Li, Pei-Xing, Wang, Zong-Ren, Zhou, Fang-Jian, Shi, Lei, Liu, Qing-Zuo, Gao, Zhen-Li, He, Da-Lin, Chen, Wei, Hsieh, Jer-Tsong, Li, Quan-Zhen, Margulis, Vitaly, Luo, Jun-Hang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846314/ https://www.ncbi.nlm.nih.gov/pubmed/26515236 http://dx.doi.org/10.1038/ncomms9699 |
Ejemplares similares
-
Validation of DAB2IP methylation and its relative significance in predicting outcome in renal cell carcinoma
por: Wang, Zong-Ren, et al.
Publicado: (2016) -
Toll-like receptor 9 interaction with CpG ODN – An in silico analysis approach
por: Zhou, Wei, et al.
Publicado: (2013) -
CRMP4 CpG Hypermethylation Predicts Upgrading to Gleason Score ≥ 8 in Prostate Cancer
por: Qin, Xiao-Ping, et al.
Publicado: (2022) -
CpGPAP: CpG island predictor analysis platform
por: Chuang, Li-Yeh, et al.
Publicado: (2012) -
Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive type
por: Cai, Qi, et al.
Publicado: (2019)